Preview Mode Links will not work in preview mode

Biohacking, nootropics, and the notion of optimizing one's human performance are on a rapid rise. Nootrobox founders Geoffrey Woo and Michael Brandt are some of the foremost thinkers in this space, and they are here to have intellectual conversations that will make you THINK every Monday.

 

We love talking directly to our THINKERS! Give us feedback, share your favorite episode, and drop suggestions for guests! 

 

We'll see you on the other side of the microphone :)

Nov 7, 2017

Today, Geoffrey Woo sits down with Dr. Dominic D'Agostino, one of the leading researchers in the field of ketosis. Dominic shares his thoughts on the implications of ketone esters and what HVMN Ketone (our new product) unlocks.

Here are a couple of key talking points from the interview:

  • Two exciting moments Dominic experienced in his years of research with exogenous ketones (adding ketones to the standard diet extended survival time and suppressed tumor growth in his mice study)
  • What are some of the most promising directions for ketones moving forward?
  • Of the many benefits stemming from the ketogenic diet and intermittent fasting, which ones can be ascribed to the ketones themselves?
  • “We’ve done a lot of work with metformin, and the exogenous ketones can blow away metformin when it comes to reducing blood glucose levels and insulin levels.”
  • The biggest misconceptions of ketone esters (can it directly cause weight loss?)
  • Dominic's own intermittent fasting routine and his applications of the practice
  • “We’ve done a lot of work with metformin, and the exogenous ketones can blow away metformin when it comes to reducing blood glucose levels and insulin levels.”
  • Why the concern of ketoacidosis caused by exogenous ketones is not valid
  • “I see [HVMN Ketone] as the next creatine, but with broader ranging implications that could even be incorporated into our food supply.”